ADINA Act

HR 4263, the ADINA Act, requires drug manufacturers to clearly label human-use drugs containing major food allergens (like peanuts or shellfish) or ingredients derived from gluten-containing grains (such as wheat or barley). This affects drug producers and pharmacies by mandating that labels state the presence of these allergens and specify the exact gluten source if applicable. The law aims to inform consumers with allergies about potential risks in medications. It applies to all drugs meeting these criteria, with implementation beginning within two years of the bill's enactment.